The economics of mental health care are broken in a specific way: the system funds crisis response and underfunds prevention — even though every dollar spent on prevention saves multiples in downstream cost. Vasl is the infrastructure for the intervention that happens before the ER visit, before the psychiatric admission, before the student withdraws. The savings are documented. The math is not close.
In downstream cost reduction — across reduced emergency psychiatric visits, lower inpatient utilization, improved student retention, and decreased crisis intervention load on clinical staff. This is not a projected figure. It is the documented range from behavioral health prevention research and from Vasl's own pilot cohort financial analysis.
These figures are drawn from Vasl's deployed pilot programs — community health centers, school-based programs, and university partnerships. Not projected from comparable platforms. Not modeled from national averages. Measured from Vasl's own member population against pre-enrollment baselines and documented national benchmarks. The methodology is available in the full outcomes report upon request.
Measured as the average reduction in Patient Health Questionnaire-8 depression symptom scores from pre-enrollment baseline to 90-day follow-up. Cohort: BIPOC, LGBTQ+, and first-generation youth ages 14–24. The PHQ-8 was selected as the outcome instrument because it is the most widely validated short-form depression screener — providing comparability with the existing evidence base while being suitable for non-clinical administration.
Retention is the most predictive single metric in behavioral health platform outcomes — a member who disengages at week two derives almost no benefit from the clinical infrastructure they were enrolled in. Vasl's 79.5% 30-day retention reflects the specific design decisions made to remove barriers: proactive coach outreach, text-first access, peer community from day one, and cultural matching that eliminates the translation burden that drives early dropout.
The nine-month national average wait for mental health support in underserved communities is not a scheduling problem — it is a structural one. Vasl removes the appointment, the insurance requirement, the waitlist, and the intake form. The median three-week figure reflects the time from initial enrollment to a member's first substantive peer group exchange or coach interaction — not merely account activation. First contact is often same-day. Three weeks is the median to meaningful engagement.
Three times faster is the conservative measure. For many members — those in communities where the average wait exceeds 12 months — the ratio is significantly higher. Speed matters not because faster is inherently better, but because delay has a clinical cost: symptoms progress, crises escalate, and the member who was ready to engage in week two is a different person by month nine. Early access is early intervention. Early intervention is prevention.
This is not a claim that clinical care is unnecessary. It is a claim that the majority of behavioral health need exists in a space that peer community and coached support can genuinely address — if that infrastructure exists. For most communities, it doesn't. Vasl builds it. And when it exists, four out of five people who use it don't escalate to the clinical tier. That is not a platform outcome. That is a prevention outcome.
"The measure of a prevention platform is not how many people it sends to therapy. It's how many people it keeps from needing to go."
What this means for cost
For every 100 members enrolled, approximately 20 will require licensed therapy. 80 will have their needs met at a dramatically lower cost per member — with measurably better retention and earlier intervention than they would have received through the standard referral pathway.
The financial case for Vasl looks different depending on who's doing the math. Universities measure in retained tuition revenue. Health plans measure in avoided utilization cost. Youth-serving organizations measure in demonstrated program impact to funders. Families measure in dollars they don't spend. The case is strong across all four.
Mental health is the leading documented cause of student dropout in the United States. Each student who withdraws due to unaddressed mental health need represents not only a human cost — it represents $35,000–$55,000 in lost tuition revenue per year, plus the downstream cost of recruitment, re-enrollment support, and academic remediation. Universities that partner with Vasl are purchasing prevention at a fraction of that cost.
"The cost of Vasl for a 500-student cohort is less than the annual tuition revenue of two retained students. The math is not close."
A single mental health emergency department visit costs $3,200–$8,400. An inpatient psychiatric admission runs $15,000–$35,000 per week. These are not edge cases in an underserved population — they are the endpoint of a predictable trajectory that begins with unaddressed distress months or years earlier. Vasl is the intervention that changes the trajectory. Health plans that fund Vasl for their Medicaid populations are purchasing prevention at roughly $14–$40 per member per month — against a single avoidable ER visit that costs many multiples of the annual investment.
"One prevented inpatient admission funds a full year of Vasl for 50 members."
YMCAs, Boys & Girls Clubs, community health centers, and faith-based youth organizations operate with two financial constraints: program budget pressure and funder accountability. Vasl addresses both. The platform's measurable outcomes — PHQ-8 improvement, retention, time to support — translate directly into the grant reporting and impact documentation that sustains program funding. The 13.5x LTV:CAC ratio reflects the long-term program value delivered against the cost of member acquisition and onboarding — documented across Vasl's community organization pilot partners.
"Funders want to see numbers. Vasl provides them — in the format grant applications actually require."
The average uninsured or underinsured outpatient mental health treatment cost in the United States is $3,000–$5,000 per year — well beyond what most families in Vasl's target population can absorb. Vasl is funded entirely through organizational partnerships: the school, the health plan, the community org, the payer covers the contract. Members access the full platform — peer groups, coaching, licensed therapy when needed — at zero out-of-pocket cost. The financial barrier is not managed. It is eliminated.
"Access is not a billing question. It never should have been."
Outcome claims without methodology are marketing. Every figure cited on this page has a defined measurement instrument, a documented population, a comparison benchmark, and an honest statement of what it does and doesn't establish. Here is how Vasl measures, reports, and — where appropriate — limits its claims.
The PHQ-8 is administered to all members at enrollment as a pre-intervention baseline. All members still active at 90 days complete a follow-up administration. The 42% improvement figure represents the mean PHQ-8 score change across this population — not a select subset. Members who disengage before 90 days are not included in the 90-day figure and are tracked separately in retention analysis.
Active retention is defined as a minimum of one meaningful platform interaction — a peer group post, a coach message exchange, a completed check-in — in the 7 days prior to the 30-day measurement point. Account activation without interaction does not count. This is a more conservative definition than most digital health platforms use, which is why Vasl reports it explicitly.
The 3-week median is calculated from the date of enrollment to the date of first substantive peer or coach interaction — not from account creation. Same-day access is frequently available; the 3-week median reflects the realistic engagement timeline across all members including those who activate accounts and engage more gradually.
Vasl's outcome figures are drawn from members enrolled in active pilot programs — community health centers, school-based programs, university partnerships — not from modeled projections or extrapolations from comparable platforms. The pilot population is majority BIPOC, LGBTQ+-inclusive, and ages 14–24. Generalizability to other populations should be assessed against the specific population and deployment context.
The Client Org Portal provides administrators with real-time aggregate data on member engagement, trend indicators, and program-level outcomes. No individual member data — name, session content, VLAP signal, or clinical notes — is accessible to organizational administrators. Aggregate data requires a minimum cohort size before being surfaced to prevent de-identification by inference.
Partner organizations receive quarterly impact reports covering PHQ-8 trend data, engagement rates, peer group activity, clinical escalation rates, and ROI calculations against documented cost benchmarks. Reports are auto-generated from platform data and are formatted for the two primary external use cases: board presentations and grant applications. The IRB study with University of Maryland is generating peer-reviewed outcome evidence that will be available to partner organizations upon completion.
Vasl's IRB-approved study with the University of Maryland is validating clinical signal accuracy and member outcome data from production deployments — generating peer-reviewed evidence that will be available to partner organizations for grant applications upon study completion.
The numbers above are aggregate across all pilot deployments. Your population, your cost baseline, and your funding structure will produce a different ROI calculation — and we'll build it with you. We provide a custom outcomes model based on your org size, population demographics, current mental health utilization costs, and available funding mechanisms.